Figure 1From: Requiring an amyloid-β1-42 biomarker may improve the efficiency of a study, and simulations may help in planning studiesPower estimation for the amnestic mild cognitive impairment group. Power for a mean to standard deviation ratio of 0.50 (20% dropout).Back to article page